3-Bromo-4,6-dichloro-1-(tetrahydro-2H-pyran-2-yl)-1H-pyrazolo[3,4-d]pyrimidine

Catalog No. :
ACQYBS078
CAS No. :
1972578-27-0
Molecular Formula :
C10H9BrCl2N4O
Molecular Weight :
352.02

IUPAC Name:3-bromo-4,6-dichloro-1-(tetrahydro-2H-pyran-2-yl)-1H-pyrazolo[3,4-d]pyrimidine

3-Bromo-4,6-dichloro-1-(tetrahydro-2H-pyran-2-yl)-1H-pyrazolo[3,4-d]pyrimidine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-Bromo-4,6-dichloro-1-(tetrahydro-2H-pyran-2-yl)-1H-pyrazolo[3,4-d]pyrimidine
IUPAC Name3-bromo-4,6-dichloro-1-(tetrahydro-2H-pyran-2-yl)-1H-pyrazolo[3,4-d]pyrimidine
Molecular FormulaC10H9BrCl2N4O
Molecular Weight352.02
SMILESClC1=NC(Cl)=C2C(N(C3CCCCO3)N=C2Br)=N1
InChI KeyPEKXWXTWRGQFNS-UHFFFAOYSA-N
Synonym1H-Pyrazolo[3,4-d]pyrimidine, 3-bromo-4,6-dichloro-1-(tetrahydro-2H-pyran-2-yl)-;3-Bromo-4,6-dichloro-1-(tetrahydro-2H-pyran-2-yl)-1H-pyrazolo[3,4-d]pyrimidine
CAS No.1972578-27-0

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACQYBS078 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACLMDI360 route compound structure diagram
    ACLMDI360944902-17-4 In Stock
  4. Then
  5. ACQYBS078 route product structure diagram
    ACQYBS0781972578-27-0
Inquiry

2. ACQYBS078 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACLMDI360 route compound structure diagram
    ACLMDI360944902-17-4 In Stock
  4. Then
  5. ACQYBS078 route product structure diagram
    ACQYBS0781972578-27-0
Inquiry

Comments (0)